Methylmalonic acid in aging and disease

Methylmalonic acid (MMA) is a byproduct of propionate metabolism linked to vitamin B12 deficiency.MMA alters cellular metabolism through direct regulation of metabolic enzymes.MMA activates succinate receptor 1 and drives inflammation.MMA acts as a signaling molecule through methylmalonylation of pr...

Full description

Saved in:
Bibliographic Details
Published inTrends in endocrinology and metabolism Vol. 35; no. 3; pp. 188 - 200
Main Authors Tejero, Joanne, Lazure, Felicia, Gomes, Ana P.
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.03.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methylmalonic acid (MMA) is a byproduct of propionate metabolism linked to vitamin B12 deficiency.MMA alters cellular metabolism through direct regulation of metabolic enzymes.MMA activates succinate receptor 1 and drives inflammation.MMA acts as a signaling molecule through methylmalonylation of proteins.MMA is linked to the development of several age-related chronic disorders. Metabolic byproducts have conventionally been disregarded as waste products without functions. In this opinion article, we bring to light the multifaceted role of methylmalonic acid (MMA), a byproduct of the propionate metabolism pathway mostly commonly known as a clinical biomarker of vitamin B12 deficiency. MMA is normally present at low levels in the body, but increased levels can come from different sources, such as vitamin B12 deficiency, genetic mutations in enzymes related to the propionate pathway, the gut microbiota, and aggressive cancers. Here, we describe the diverse metabolic and signaling functions of MMA and discuss the consequences of increased MMA levels, such as during the aging process, for several age-related human pathologies. Metabolic byproducts have conventionally been disregarded as waste products without functions. In this opinion article, we bring to light the multifaceted role of methylmalonic acid (MMA), a byproduct of the propionate metabolism pathway mostly commonly known as a clinical biomarker of vitamin B12 deficiency. MMA is normally present at low levels in the body, but increased levels can come from different sources, such as vitamin B12 deficiency, genetic mutations in enzymes related to the propionate pathway, the gut microbiota, and aggressive cancers. Here, we describe the diverse metabolic and signaling functions of MMA and discuss the consequences of increased MMA levels, such as during the aging process, for several age-related human pathologies.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1043-2760
1879-3061
DOI:10.1016/j.tem.2023.11.001